This is the authors' abstract. We don't add key points for this paper.
In preterm infants receiving intravenous lipids, triglyceride levels should be regularly monitored, and adjustments considered if levels exceed 3 mmol/L. However, specific frequency for testing remains undefined in guidelines, and clinical decisions should be individually tailored.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Tripdatabase (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: